Three new C21 steroidal glycosides named inamoside E （1）, inamoside F （2） and inamoside G （3） were isolated from the roots of Cynanchum inamoenum （Maxim.） Loes. Their structures were determined by spectroscopi...Three new C21 steroidal glycosides named inamoside E （1）, inamoside F （2） and inamoside G （3） were isolated from the roots of Cynanchum inamoenum （Maxim.） Loes. Their structures were determined by spectroscopic analysis, especially by ID and 2D NMR experiments.展开更多
BACKGROUND A series of long non-coding RNAs(lncRNAs)have been reported to play a crucial role in cancer biology.Some previous studies report that lncRNA CDKN2B-AS1 is involved in some human malignancies.However,its ro...BACKGROUND A series of long non-coding RNAs(lncRNAs)have been reported to play a crucial role in cancer biology.Some previous studies report that lncRNA CDKN2B-AS1 is involved in some human malignancies.However,its role in hepatocellular carcinoma(HCC)has not been fully deciphered.AIM To decipher the role of CDKN2B-AS1 in the progression of HCC.METHODS CDKN2B-AS1 expression in HCC was detected by quantitative real-time polymerase chain reaction.The malignant phenotypes of Li-7 and SNU-182 cells were detected by the CCK-8 method,EdU method,and flow cytometry,respectively.RNA immunoprecipitation was executed to confirm the interaction between CDKN2B-AS1 and E2F transcription factor 1(E2F1).Luciferase reporter assay and chromatin immunoprecipitation were performed to verify the binding of E2F1 to the promoter of G protein subunit alpha Z(GNAZ).E2F1 and GNAZ were detected by western blot in HCC cells.RESULTS In HCC tissues,CDKN2B-AS1 was upregulated.Depletion of CDKN2B-AS1 inhibited the proliferation of HCC cells,and the depletion of CDKN2B-AS1 also induced cell cycle arrest and apoptosis.CDKN2B-AS1 could interact with E2F1.Depletion of CDKN2B-AS1 inhibited the binding of E2F1 to the GNAZ promoter region.Overexpression of E2F1 reversed the biological effects of depletion of CDKN2B-AS1 on the malignant behaviors of HCC cells.CONCLUSION CDKN2B-AS1 recruits E2F1 to facilitate GNAZ transcription to promote HCC progression.展开更多
目的:检测转录因子E2F1与生长阻滞和DNA损伤诱导蛋白45g(GADD45g)基因在急性髓系白血病(AML)患者中表达的相关性,探讨GADD45g是否通过抑制E2F1诱导AML细胞DNA损伤、凋亡、衰老、周期阻滞和提高药物敏感性。方法:选取2013年1月至2016年1...目的:检测转录因子E2F1与生长阻滞和DNA损伤诱导蛋白45g(GADD45g)基因在急性髓系白血病(AML)患者中表达的相关性,探讨GADD45g是否通过抑制E2F1诱导AML细胞DNA损伤、凋亡、衰老、周期阻滞和提高药物敏感性。方法:选取2013年1月至2016年12月中国医学科学院血液病医院初诊为AML患者32例骨髓标本及AML细胞系U937、HL60、THP-1和Molm-13,用q PCR检测组织和细胞中GADD45g和E2F1 m RNA的表达水平,并分析其相关性。构建E2F1过表达载体,并制备重组慢病毒在过表达GADD45g的Molm-13和THP-1细胞中过表达E2F1,通过彗星实验、Annexin V/7AAD流式细胞术、β-半乳糖苷酶染色和PI染色流式细胞术等确定GADD45g是否通过抑制E2F1对AML细胞发挥抑癌作用。结果:AML患者骨髓和细胞系中GADD45g和E2F1 m RNA的表达呈显著负相关(r=–0.663,P<0.01)。GADD45g在AML细胞系中过表达显著抑制了E2F1的表达(均P<0.01)。成功构建同时过表达GADD45g和E2F1的Molm-13和THP-1细胞,与对照组比较,过表达组细胞GADD45g和E2F1蛋白表达水平均显著升高(均P<0.01)。与过表达GADD45g的细胞相比,同时过表达GADD45g和E2F1细胞的凋亡、衰老率和DNA损伤水平均显著降低(均P<0.01);在过表达GADD45g的细胞中过表达E2F1逆转了GADD45g诱导的周期阻滞(均P<0.01),进而降低了过表达GADD45g对化疗药物的敏感性(均P<0.01)。结论:GADD45g通过抑制E2F1在AML中发挥抗肿瘤作用。展开更多
文摘Three new C21 steroidal glycosides named inamoside E （1）, inamoside F （2） and inamoside G （3） were isolated from the roots of Cynanchum inamoenum （Maxim.） Loes. Their structures were determined by spectroscopic analysis, especially by ID and 2D NMR experiments.
文摘BACKGROUND A series of long non-coding RNAs(lncRNAs)have been reported to play a crucial role in cancer biology.Some previous studies report that lncRNA CDKN2B-AS1 is involved in some human malignancies.However,its role in hepatocellular carcinoma(HCC)has not been fully deciphered.AIM To decipher the role of CDKN2B-AS1 in the progression of HCC.METHODS CDKN2B-AS1 expression in HCC was detected by quantitative real-time polymerase chain reaction.The malignant phenotypes of Li-7 and SNU-182 cells were detected by the CCK-8 method,EdU method,and flow cytometry,respectively.RNA immunoprecipitation was executed to confirm the interaction between CDKN2B-AS1 and E2F transcription factor 1(E2F1).Luciferase reporter assay and chromatin immunoprecipitation were performed to verify the binding of E2F1 to the promoter of G protein subunit alpha Z(GNAZ).E2F1 and GNAZ were detected by western blot in HCC cells.RESULTS In HCC tissues,CDKN2B-AS1 was upregulated.Depletion of CDKN2B-AS1 inhibited the proliferation of HCC cells,and the depletion of CDKN2B-AS1 also induced cell cycle arrest and apoptosis.CDKN2B-AS1 could interact with E2F1.Depletion of CDKN2B-AS1 inhibited the binding of E2F1 to the GNAZ promoter region.Overexpression of E2F1 reversed the biological effects of depletion of CDKN2B-AS1 on the malignant behaviors of HCC cells.CONCLUSION CDKN2B-AS1 recruits E2F1 to facilitate GNAZ transcription to promote HCC progression.
文摘目的:检测转录因子E2F1与生长阻滞和DNA损伤诱导蛋白45g(GADD45g)基因在急性髓系白血病(AML)患者中表达的相关性,探讨GADD45g是否通过抑制E2F1诱导AML细胞DNA损伤、凋亡、衰老、周期阻滞和提高药物敏感性。方法:选取2013年1月至2016年12月中国医学科学院血液病医院初诊为AML患者32例骨髓标本及AML细胞系U937、HL60、THP-1和Molm-13,用q PCR检测组织和细胞中GADD45g和E2F1 m RNA的表达水平,并分析其相关性。构建E2F1过表达载体,并制备重组慢病毒在过表达GADD45g的Molm-13和THP-1细胞中过表达E2F1,通过彗星实验、Annexin V/7AAD流式细胞术、β-半乳糖苷酶染色和PI染色流式细胞术等确定GADD45g是否通过抑制E2F1对AML细胞发挥抑癌作用。结果:AML患者骨髓和细胞系中GADD45g和E2F1 m RNA的表达呈显著负相关(r=–0.663,P<0.01)。GADD45g在AML细胞系中过表达显著抑制了E2F1的表达(均P<0.01)。成功构建同时过表达GADD45g和E2F1的Molm-13和THP-1细胞,与对照组比较,过表达组细胞GADD45g和E2F1蛋白表达水平均显著升高(均P<0.01)。与过表达GADD45g的细胞相比,同时过表达GADD45g和E2F1细胞的凋亡、衰老率和DNA损伤水平均显著降低(均P<0.01);在过表达GADD45g的细胞中过表达E2F1逆转了GADD45g诱导的周期阻滞(均P<0.01),进而降低了过表达GADD45g对化疗药物的敏感性(均P<0.01)。结论:GADD45g通过抑制E2F1在AML中发挥抗肿瘤作用。
